| 000 | 01715 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516202545.0 | ||
| 264 | 0 | _c20150115 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1557-8615 | ||
| 024 | 7 |
_a10.1016/j.jcrc.2014.02.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVassalo, Juliana | |
| 245 | 0 | 0 |
_aAntiphospholipid antibodies in critically ill patients with cancer: a prospective cohort study. _h[electronic resource] |
| 260 |
_bJournal of critical care _cAug 2014 |
||
| 300 |
_a533-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Antiphospholipid _xblood |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aCritical Illness |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xanalysis |
| 650 | 0 | 4 |
_aHematologic Neoplasms _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntensive Care Units |
| 650 | 0 | 4 |
_aLupus Coagulation Inhibitor _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRenal Replacement Therapy |
| 650 | 0 | 4 |
_aSepsis _xblood |
| 650 | 0 | 4 |
_abeta 2-Glycoprotein I _xblood |
| 700 | 1 | _aSpector, Nelson | |
| 700 | 1 | _ade Meis, Ernesto | |
| 700 | 1 | _aRabello, Lígia S C F | |
| 700 | 1 | _aRosolem, Maíra M | |
| 700 | 1 | _ado Brasil, Pedro E A A | |
| 700 | 1 | _aSalluh, Jorge I F | |
| 700 | 1 | _aSoares, Márcio | |
| 773 | 0 |
_tJournal of critical care _gvol. 29 _gno. 4 _gp. 533-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcrc.2014.02.005 _zAvailable from publisher's website |
| 999 |
_c23640620 _d23640620 |
||